Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-08 Sale(A) |
2022-03-08 9:41 pm |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
2,500 | $30.8 | $77,000 | 193,135 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 7:58 pm |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
54,962 | $29.28 | $1,609,321 | 183,135 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 7:35 pm |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
21,710 | $30.5 | $662,208 | 17,232 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 7:32 pm |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
51,168 | $30.63 | $1,567,394 | 10,000 (Direct) |
View |
| 2022-01-21 Purchase |
2022-01-21 5:04 pm |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
700 | $28.81 | $20,167 | 700 (Direct) |
View |
| 2021-12-06 Purchase |
2021-12-07 4:13 pm |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
4,000 | $24.4 | $97,600 | 4,000 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-16 8:40 pm |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
17,557 | $31.33 | $550,061 | 210,186 (Direct) |
View |
| 2021-05-28 Sale |
2021-06-01 4:11 pm |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
6,067 | $18.81 | $114,120 | 32,232 (Direct) |
View |
| 2021-05-27 Sale |
2021-06-01 4:07 pm |
Xenon Pharmaceuticals Inc. | XENE | HOLLER FRANK A Director |
11,064 | $18.68 | $206,701 | 144,837 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-04 Tax Withholding |
2022-03-08 7:58 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
963 | $31.42 | 183,135 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:58 pm |
N/A 2022-03-10 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
30,864 | $0 | 183,135 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:58 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
30,864 | $3.67 | 183,135 (Direct) |
View |
| 2022-03-07 Tax Withholding |
2022-03-08 7:58 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
1,990 | $30.23 | 183,135 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 7:35 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
696 | $31.42 | 17,232 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:35 pm |
N/A 2022-03-10 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
7,406 | $0 | 17,232 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:35 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
7,406 | $3.67 | 17,232 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
6,685 | $31.42 | 10,000 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:32 pm |
N/A 2027-03-12 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
67,500 | $0 | 10,000 (Direct) |
View |
| 2022-03-07 Exercise |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
40,000 | $6.76 | 10,000 (Direct) |
View |
| 2022-03-07 Tax Withholding |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
9,647 | $30.23 | 10,000 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
27,500 | $8.4 | 10,000 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 4:04 pm |
N/A 2021-12-31 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
3,086 | $0 | 66,819 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 4:04 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
3,086 | $3.67 | 66,819 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 4:20 pm |
N/A 2021-12-31 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
2,057 | $0 | 38,130 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 4:20 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
2,057 | $3.67 | 38,130 (Direct) |
View |
| 2021-08-23 Option Award |
2021-08-25 4:12 pm |
N/A 2031-08-22 |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2021-08-25 4:05 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2021-03-17 Acquisition |
2021-06-04 7:20 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
100 | $19.49 | 46,173 (Indirect) |
View |
| 2021-06-03 Option Award |
2021-06-04 7:20 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
10,000 | $0 | 46,173 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 9:16 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 9:09 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 9:07 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | Hayden Michael R Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 9:04 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 9:02 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 9:00 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2021-06-03 8:57 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
0 | $0 | 0 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 4:46 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 4:42 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2021-06-03 4:35 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
0 | $0 | 71,982 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-01 4:11 pm |
N/A 2021-05-28 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
25,719 | $0 | 32,232 (Direct) |
View |
| 2021-05-28 Tax Withholding |
2021-06-01 4:11 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
4,216 | $18.91 | 32,232 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-01 4:11 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
13,374 | $3.85 | 32,232 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-01 4:11 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
12,345 | $3.76 | 32,232 (Direct) |
View |
| 2021-05-27 Exercise |
2021-06-01 4:07 pm |
N/A 2021-05-28 |
Xenon Pharmaceuticals Inc. | XENE | HOLLER FRANK A Director |
39,094 | $0 | 144,837 (Direct) |
View |
| 2021-05-27 Tax Withholding |
2021-06-01 4:07 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | HOLLER FRANK A Director |
6,418 | $18.88 | 144,837 (Direct) |
View |
| 2021-05-27 Exercise |
2021-06-01 4:07 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | HOLLER FRANK A Director |
39,094 | $3.76 | 144,837 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 4:11 pm |
N/A 2021-05-28 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. CEO |
22,633 | $0 | 227,743 (Direct) |
View |
| 2021-05-24 Tax Withholding |
2021-05-26 4:11 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. CEO |
5,076 | $19.17 | 227,743 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 4:11 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. CEO |
22,633 | $3.76 | 227,743 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-20 4:18 pm |
N/A 2021-06-30 |
Xenon Pharmaceuticals Inc. | XENE | TARNOW MICHAEL M Director |
8,229 | $0 | 77,942 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-20 4:18 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | TARNOW MICHAEL M Director |
6,172 | $3.67 | 77,942 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-20 4:18 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | TARNOW MICHAEL M Director |
2,057 | $3.87 | 77,942 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-20 4:13 pm |
N/A 2027-05-31 |
Xenon Pharmaceuticals Inc. | XENE | Hayden Michael R Director |
3,500 | $0 | 322,685 (Direct) |
View |
| 2021-05-18 Exercise |
2021-05-20 4:13 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | Hayden Michael R Director |
3,500 | $3.85 | 322,685 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:45 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:43 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
65,000 | $0 | 65,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:41 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. CEO |
225,000 | $0 | 225,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:37 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CFO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:35 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 65,000 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 5:59 pm |
N/A 2022-12-31 |
Xenon Pharmaceuticals Inc. | XENE | Hayden Michael R Director |
46,296 | $0 | 319,185 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-18 5:59 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | Hayden Michael R Director |
10,288 | $3.67 | 319,185 (Indirect) |
View |
| 2021-02-16 Exercise |
2021-02-18 5:59 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | Hayden Michael R Director |
36,008 | $2.68 | 319,185 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-15 4:39 pm |
N/A 2020-12-31 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
3,086 | $0 | 63,733 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-15 4:39 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
3,086 | $3.76 | 63,733 (Direct) |
View |
| 2020-11-05 Option Award |
2020-11-05 7:14 pm |
N/A 2030-11-04 |
Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-11-05 7:02 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director |
0 | $0 | 0 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-29 4:27 pm |
N/A 2020-12-31 |
Xenon Pharmaceuticals Inc. | XENE | TARNOW MICHAEL M Director |
10,288 | $0 | 69,713 (Direct) |
View |
| 2020-10-28 Gift |
2020-10-29 4:27 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | TARNOW MICHAEL M Director |
10,288 | $0 | 69,713 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-29 4:27 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | TARNOW MICHAEL M Director |
5,144 | $3.76 | 69,713 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-29 4:20 pm |
N/A 2020-12-31 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
2,057 | $0 | 36,073 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-29 4:20 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
2,057 | $3.76 | 36,073 (Direct) |
View |
| 2020-08-20 Other |
2020-08-24 4:41 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. CEO |
45,000 | $0 | 255,186 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 6:38 pm |
N/A 2030-08-16 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |